Search filters

List of works by Martin Dreyling

2-D PAGE-based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma

scientific article

A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms

scientific article

A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens ⬇️

scientific article published on October 1, 2010

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

scientific article

A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse la

scientific article

A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas

scientific article

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

scientific article published on 13 June 2016

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma ⬇️

scientific article published on August 26, 2011

Bendamustine for patients with B cell lymphoid malignancies

scientific article

Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia ⬇️

scientific article published on September 12, 2012

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

scientific article

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

scientific article published on 14 July 2016

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle c

scientific article

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network

scientific article published on 31 March 2014

Current management of follicular lymphomas

scientific article published on 31 October 2006

Current management of mantle cell lymphoma

scientific article published on January 2007

Current status and perspective of antibody therapy in follicular lymphoma.

scientific article

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

scientific article published on 9 December 2004

Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.

scientific article

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

scientific article published on 25 August 2005

Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

scientific article

High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).

scientific article

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

scientific article published on 28 May 2015

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network

scientific article published in October 2005

How to treat old MCL patients: one size fits it all?

scientific article

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

scientific article published on 24 January 2005

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis

scientific article published on May 2007

Impact of age on genetics and treatment efficacy in follicular lymphoma

scientific article published on 15 March 2018

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

scientific article

Investigational strategies in autologous stem cell transplantation for follicular lymphoma

scientific article published on September 2006

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network

scientific article

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

scientific article

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

scientific article

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

scientific article

Management of Mantle Cell Lymphoma: Key Challenges and Next Steps ⬇️

scientific article published on October 1, 2010

Mantle cell lymphoma: Therapeutic strategies are different from CLL ⬇️

scientific article published on June 1, 2003

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era ⬇️

scientific article published on October 12, 2010

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop

scientific article

Mantle cell lymphoma: state-of-the-art management and future perspective

scientific article published on December 2009

Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.

scientific article

Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study

scientific article published on 24 December 2015

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

scientific article published in December 2004

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

scientific article

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group

scientific article published on 6 July 2004

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

scientific article

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma

scientific article

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas ⬇️

scientific article published on December 14, 2012

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8

scientific article

Postibrutinib outcomes in patients with mantle cell lymphoma

scientific article

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation

scientific article published on 8 January 2013

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

scientific article

Proteome- and microarray-based expression analysis of lymphoma cell lines identifies a p53-centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma.

scientific article

Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma.

scientific article

Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphoma.

scientific article published on August 2006

Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease

scientific article

Rituximab plus chemotherapy in follicular and mantle cell lymphomas

scientific article

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.

scientific article

Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study

scientific article

Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded platelets.

scientific article

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

scientific article

The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date

scientific article

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

scientific article

The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity

scientific article

The role of fludarabine in the treatment of follicular and mantle cell lymphoma

scientific article published in September 2004

The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?

scientific article

Transplantation strategies for patients with follicular lymphoma

scientific article

Treatment strategies in follicular lymphomas: current status and future perspectives

scientific article

Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group

scientific article published on August 2007

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network

scientific article published on 18 August 2011

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network

scientific article

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

article

Paulina is supported by:

About Paulina

Help